VIROGIN BIOTECH
Virogin Biotech Ltd. ("Virogin") was founded in 2015, with the headquarters located in Vancouver, Canada. They are dedicated to developing the next generation of oncolytic virus (OV) therapeutics using their novel Synerlyticâ„¢ technical platform for improved cancer treatment. By exploring innovative approaches to immunotherapy, Virogin is committed to becoming a world leader in the field of immuno-oncology.
VIROGIN BIOTECH
Industry:
Biotechnology Health Care
Founded:
2015-01-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.virogin.com
Total Employee:
51+
Status:
Active
Contact:
+86 (755) 33122597
Total Funding:
204 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving SPF Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics LetsEncrypt
Similar Organizations
BioIntervene
BioIntervene is engages in drug discovery and development.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Curon Biopharma
Curon Biopharma is a Healthcare company.
Medtrum
Medtrum is a diabetes management medical device developer.
Micot
Micot is a peptide and protein drug developer.
PegBio
PegBio is a Chinese innovative drug developer.
Percutek Therapeutics
Percutek Therapeutics is a medical device developer.
Qihan Biotech
Qihan Biotech is a gene-editing organ transplantation technology developer.
Semler Scientific
Semler Scientific is an emerging medical risk-assessment company.
Silicon Therapeutics
Silicon Therapeutics is a fully integrated drug design, research, and development company.
Current Advisors List
Board_member
Current Employees Featured
Chris Huang Co-Founder & Chief Executive Officer @ Virogin Biotech
Co-Founder & Chief Executive Officer
William Jia Co-Founder & Chief Scientific Officer @ Virogin Biotech
Co-Founder & Chief Scientific Officer
Founder
Investors List
China Life Healthcare Fund
China Life Healthcare Fund investment in Series D - Virogin Biotech
Linden Asset
Linden Asset investment in Series D - Virogin Biotech
CDH Investments
CDH Investments investment in Series C - Virogin Biotech
Shenzhen Xiaoxi Holdings
Shenzhen Xiaoxi Holdings investment in Series C - Virogin Biotech
China Merchants Venture Capital
China Merchants Venture Capital investment in Series C - Virogin Biotech
Korea Investment Partners
Korea Investment Partners investment in Series C - Virogin Biotech
CMG-SDIC Capital Management
CMG-SDIC Capital Management investment in Series C - Virogin Biotech
Peking University Mingde Fund
Peking University Mingde Fund investment in Series C - Virogin Biotech
Pan-Lin Capital
Pan-Lin Capital investment in Series C - Virogin Biotech
Purity Star
Purity Star investment in Series B - Virogin Biotech
Official Site Inspections
http://www.virogin.com
- Host name: 23.185.0.3
- IP address: 23.185.0.3
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Virogin Biotech"
About - Virogin
Founded in Canada in 2015, Virogin aims to unleash synergy between oncolytic virotherapy and mRNA vaccines in the battle against cancer. Our vision is to be a global, best-in-class immuno …See details»
Virogin Biotech
Virogin Biotech is a clinical-stage immuno-oncology company developing innovative therapies for the treatment of cancer. We have developed two platforms: (1) innovative HSV-1 based …See details»
Virogin Biotech - Crunchbase Company Profile
Virogin Biotech Ltd. ("Virogin") was founded in 2015, with the headquarters located in Vancouver, Canada. They are dedicated to developing the next generation of oncolytic virus (OV) therapeutics using their novel Synerlytic™ …See details»
Virogin Biotech - LinkedIn
Virogin Biotech aims to be a global, best-in-class oncolytic virus company that creates impactful drugs for patients of the highest medical need. Our platform technology focuses on creating...See details»
Virogin Biotech Company Profile 2024: Valuation, …
Developer of oncolytic virus technology designed to treat tumors and inhibit tumor growth.See details»
Contact - Virogin
If you are interested in investment or partnership opportunities, please contact us at: partnering@virogin.comSee details»
Virogin Biotech - Org Chart, Teams, Culture & Jobs - The Org
Virogin Biotech aims to be a global, best-in-class oncolytic virus company that creates impactful drugs for patients of the highest medical need. View Virogin Biotech's up-to-date org chart, …See details»
Virogin Biotech Limited - VentureRadar
Virogin Biotech was founded in 2015, with a vision to be a global, best-in-class oncolytic virus company that creates impactful drugs for patients of highest medical need. We are a company …See details»
Virogin Biotech to Form a Joint Venture with China’s Largest ...
The Virogin-CNBG Joint Venture will combine Virogin’s expertise in oncolytic virology and its HSV-1 based platform technology with CNBG’s deep clinical development, manufacturing, and …See details»
Virogin Biotech | 领英 - 领英 (ä¸å›½)
Virogin Biotech aims to be a global, best-in-class oncolytic virus company that creates impactful drugs for patients of the highest medical need. Our platform technology focuses on creating...See details»
Virogin Biotech Company Profile - Office Locations, Competitors
Virogin Biotech is a company that specializes in oncolytic virotherapy. Its platform technology focuses on creating long-lasting antitumor immunity by capitalizing on a transient antiviral …See details»
Virogin Biotech - Overview, News & Similar companies - ZoomInfo
Nov 15, 2022 · Who is Virogin Biotech. Virogin Biotech is a oncolytic virus company that creates impactful drugs for patients of highest medical need. Established in 2015, Virogin Biotec h is …See details»
Virogin Biotech and MD Anderson Announce Strategic …
Sep 8, 2022 · Virogin Biotech & MD Anderson Cancer Center announced collaboration to accelerate development of investigational treatments for patients with advanced cancers.See details»
Careers - Virogin
Virogin has a global presence in Canada, USA, China, and Australia. We are headquartered in Richmond, British Columbia, Canada with lab work done in Canada and China, clinical trials in …See details»
Virogin Biotech Announces Completion of $62 Million in Series C ...
Sep 29, 2020 · Virogin Biotech is a clinical stage oncolytic virus company that is developing next-generation oncolytic virotherapies to enhance the systemic antitumor immunity.See details»
Virogin Biotech Begins Phase I Trial of Oncolytic Virus Therapy …
Nov 18, 2022 · Virogin, headquartered in Vancouver, British Columbia, is developing viral therapies with anti-tumor activity that are designed to also activate the innate and adaptive …See details»
Virogin Biotech Announces Closing of $127 Million in Series D2 ...
Dec 15, 2021 · Virogin Biotech is a clinical stage biotech company developing next-generation immuno-oncolytic therapeutics to enhance the systemic antitumor immunity.See details»
Team - Virogin
We are a company with over 50 employees and R&D facilities in Vancouver, Canada and Shanghai, China. William Jia, PhD. Ronghua Zhao, MD, PhD. Dr. Susie Tan, MD, PhD. …See details»
Virogin Biotech Receives IND Approval from the U.S. FDA for VG201
Feb 3, 2022 · VANCOUVER, B.C. – Virogin Biotech, a clinical-stage biotech company is pleased to announce that their Investigational New Drug (IND) application for VG201 has been granted …See details»
Virogin Biotech Receives IND Approval from the U.S. FDA for VG161
Feb 2, 2022 · Virogin Biotech, a clinical-stage biotech company, announces their Investigational New Drug application for VG161 has been granted by the U.S. FDA, allowing Virogin to initiate …See details»